Comparison of D. pteronyssinus levels collected in participant homes at baseline and at end of study with measure of number of subjects with a significant change
| Group | Value | 95% CI |
|---|---|---|
| Telemedicine Arm | 0 | |
| Standard of Care Education | 0 |
Last reviewed · How we verify
Effectiveness of Telemedicine Home Assessments for Identification and Reduction of Asthma Triggers
NA trial testing Standard of Care Education in Asthma in Children in 27 participants. Completed in 1 September 2022.
| Lead sponsor | University of Arkansas |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 27 |
| Start date | 26 September 2019 |
| Primary completion | 8 August 2022 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across United States |
University of Arkansas
Adults 5 to 18, any sex, with Asthma in Children. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Comparison of D. pteronyssinus levels collected in participant homes at baseline and at end of study with measure of number of subjects with a significant change
| Group | Value | 95% CI |
|---|---|---|
| Telemedicine Arm | 0 | |
| Standard of Care Education | 0 |
We will measure differences in ACT scores from baseline to 6 months between the Telemedicine and Standard of Care groups. Asthma Control Test (ACT) is a 5 question (\<12 years of age) or 7 question (\>/= 12 years of age) test utilized to assess asthma control. Scores range from 0 to 25. The maximum score is 25 and a score of 19 or less indicates "not well-controlled" asthma.
| Group | Value | 95% CI |
|---|---|---|
| Telemedicine Arm | 23.3 | ± 2.36 |
| Standard of Care Education | 21.25 | ± 2.165 |
| Group | Value | 95% CI |
|---|---|---|
| Telemedicine Arm | 23.3 | ± 2.36 |
| Standard of Care Education | 22 | ± 3 |
Patient satisfaction measured by standardized survey. Respondents were asked "How satisfied were you with your overall experience?" and were scored on a scale from "Complete Satisfied" to "Not at All Satisfied"
| Group | Value | 95% CI |
|---|---|---|
| Telemedicine Group | 4 | |
| Standard of Care Education | 4 |
| Group | Value | 95% CI |
|---|---|---|
| Telemedicine Group | 2 | |
| Standard of Care Education | 1 |
| Group | Value | 95% CI |
|---|---|---|
| Telemedicine Group | 0 | |
| Standard of Care Education | 0 |
| Group | Value | 95% CI |
|---|---|---|
| Telemedicine Group | 0 | |
| Standard of Care Education | 0 |
| Group | Value | 95% CI |
|---|---|---|
| Telemedicine Group | 2 | |
| Standard of Care Education | 4 |
The study is about comparing asthma home assessments/interventions by telemedicine compared to providing education alone. Interactive Video (IAV) defines telemedicine. It allows two-way communication in real-time with both audio and visual communication between the subject and someone from the study team. It is similar to using Face Time on a mobile device. Asthma home assessments/interventions are used to identify things in a home that can make asthma symptoms worse, called triggers. Reducing these triggers in the home can improve asthma.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04896502.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing